Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). (Q33377350)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). (English)

1 reference

Europe PubMed Central

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

serous carcinoma

1 reference

based on heuristic

inferred from title

author name string

Abbie L Fields

1

1 reference

Europe PubMed Central

26 July 2017

Mark H Einstein

2

1 reference

Europe PubMed Central

26 July 2017

Akiva P Novetsky

3

1 reference

Europe PubMed Central

26 July 2017

Juliana Gebb

4

1 reference

Europe PubMed Central

26 July 2017

Gary L Goldberg

5

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

8 November 2007

1 reference

Europe PubMed Central

26 July 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

26 July 2017

108

1 reference

Europe PubMed Central

26 July 2017

1

1 reference

Europe PubMed Central

26 July 2017

201-206

1 reference

Europe PubMed Central

26 July 2017

Virulence of papillary endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Uterine papillary serous carcinoma: what have we learned over the past quarter century?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Outcomes in surgical stage I uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Optimal management for surgically Stage 1 serous cancer of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

The role of omentectomy during the surgical staging of uterine serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.09.025

7 January 2021

Identifiers

10.1016/J.YGYNO.2007.09.025

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33377350&oldid=1536541561"